Hsbc Holdings PLC Aslan Pharmaceuticals LTD Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$2.91 - $4.5 $580,172 - $897,174	-199,372 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.1 - $4.8 $1.05 Million - $1.62 Million	-337,424 Reduced 62.86%	199,372 $855,000
Q4 2018 Feb 13, 2019	SELL	$2.86 - $8.0 $88,136 - $246,536	-30,817 Reduced 5.43%	536,796 $1.93 Million
Q3 2018 Nov 13, 2018	SELL	$7.3 - $8.5 $2,664 - $3,102	-365 Reduced 0.06%	567,613 $4.53 Million
Q2 2018 Aug 10, 2018	BUY	$5.48 - $10.24 $3.11 Million - $5.82 Million	567,978 New	567,978 $5 Million

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.